The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cns Pharmaceuticals Inc shares valued at $10,000 were purchased by Gumulka Jerzy on Feb 01 ’24. At $0.30 per share, Gumulka Jerzy acquired 33,333 shares. The insider’s holdings grew to 43,006 shares worth approximately $4730.66 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Evans Carl Anthony purchased 33,333 shares, netting a total of over 10,000 in proceeds. Following the buying of shares at $0.30 each, the insider now holds 33,458 shares.
Before that, Downs Christopher had added 66,666 shares to its account. In a trade valued at $20,000, the Chief Financial Officer bought Cns Pharmaceuticals Inc shares for $0.30 each. Upon closing the transaction, the insider’s holdings increased to 66,666 shares, worth approximately $11378.18.
As published in a research note from Ladenburg Thalmann on December 28, 2020, Cns Pharmaceuticals Inc [CNSP] has been rated down from a Buy to a Neutral. Analysts at Ladenburg Thalmann started covering the stock with ‘”a Buy”‘ outlook in a report released in late August.
Analyzing CNSP Stock Performance
During the last five days, there has been a surge of approximately 2.61%. Over the course of the year, Cns Pharmaceuticals Inc shares have dropped approximately -99.83%. Shares of the company reached a 52-week high of $65.0000 on 01/02/24 and a 52-week low of $0.0955 on 08/16/24. A 50-day SMA is recorded $0.1201, while a 200-day SMA reached $4.9701. Nevertheless, trading volume fell to 1.74 million shares from 2.3 million shares the previous day.
Support And Resistance Levels for Cns Pharmaceuticals Inc (CNSP)
According to the 24-hour chart, there is a support level at 0.1007, which, if violated, would cause prices to drop to 0.0953. In the upper region, resistance lies at 0.1107. The next price resistance is at 0.1153. RSI (Relative Strength Index) is 41.90 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0027, which suggests the price will decrease in the coming days. Percent R is at 64.85%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
